Janus Henderson Group’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-150,554
Closed -$17.2M 2727
2021
Q4
$17.2M Buy
+150,554
New +$17.2M 0.01% 821
2020
Q4
Sell
-14,971
Closed -$1.67M 1447
2020
Q3
$1.67M Hold
14,971
﹤0.01% 1083
2020
Q2
$1.57M Buy
+14,971
New +$1.6M ﹤0.01% 1063

Other funds holding BSX.PRA

Janus Henderson Group's BSX.PRA Position: Q1 2022 in Review

Janus Henderson Group sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q1 2022, closing a stake of 150,554 shares — an estimated $17.2M sold.

Janus Henderson Group first reported a position in BSX.PRA in Q2 2020 and held it in 3 quarters. The position peaked at $17.2M in Q4 2021. 44 funds tracked by Wall St. Rank hold BSX.PRA as of Q1 2022.

  • Janus Henderson Group reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q1 2022 after selling out during the quarter.
  • Janus Henderson Group sold 150,554 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q1 2022, an estimated $17.2M.
  • Janus Henderson Group first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 3 quarters.
  • Janus Henderson Group's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $17.2M in Q4 2021.
  • 44 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q1 2022.

Based on Janus Henderson Group's 13F filing for Q1 2022, filed 16 May 2022.